sponsored content August 15, 2024 When it comes to choosing a myopia management treatment modality, there are several factors to consider beyond...
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
July 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The article “Effectiveness of Orthokeratology and Myopia Control Spectacles in a...
June 3, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
May 28, 2024 BERLIN, Germany — Dopavision has announced early findings from its clinical trial for MyopiaX-1. The six-month outcomes of the...
May 1, 2024 By Hashim Ali Khan, OD, FAAO, Dipl AAO, PhD Candidate at Brien Holden Vision Institute, Sydney While a substantial...
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
April 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Topical low-concentration atropine eye drops to help slow the progression of...
December 1, 2023 By Dr. Melinda Toomey, BAppSc (Optom), MOptom, GradCertOcTher, MBA, PhD Managing myopia is a multifaceted process that requires a...
September 1, 2022 Is percentage treatment effect the most accurate way to express myopia control efficacy? Treatment effect has been expressed in...
April 1, 2022 By Geetha Sravani, PhD Candidate, Brien Holden Vision Institute Myopia prevalence is high in many Asian countries. To delay...